BRINTER

BRINTER

Biotechnology Research

Winston-Salem, North Carolina 3,138 followers

U.S MedTech - TechStars‘24 company | 3D bioprinted Mesh Implants for tissue repairs with Regenerative Medicine features.

About us

3D BIOPRINTED TISSUE We're a first-mover U.S. MedTech platform company developing a pipeline of mesh implants with regenerative medicine capabilities. Thanks to our proprietary 3D bioprinters our implants come with never-before-seen features aiming for faster healing and lower patient complications. We aim to disrupt the standard of care for soft tissue repairs in orthopedics, general surgery, and reconstructive surgery. Our first Mesh 510(k) implants will be commercial in 2025 for tendon management, followed by applications for multiple hernias and eventually post-mastectomy/breast reconstruction.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Winston-Salem, North Carolina
Type
Privately Held
Founded
2021

Locations

Employees at BRINTER

Updates

Similar pages

Funding

BRINTER 2 total rounds

Last Round

Seed

US$ 750.0K

See more info on crunchbase